Académique Documents
Professionnel Documents
Culture Documents
Born Neonates
Reese H. Clark, Pam Thomas and Joyce Peabody
Pediatrics 2003;111;986
The online version of this article, along with updated information and services, is
located on the World Wide Web at:
http://pediatrics.aappublications.org/content/111/5/986.full.html
986
Study Population
Neonates discharged from 124 neonatal intensive care units
(NICUs) managed by Pediatrix Medical Group, Inc between January 1, 1997, and December 31, 2000, who were 23 to 34 weeks
estimated gestational age without congenital anomalies and who
were born at and discharged from the same NICU (N 24 371)
were eligible for inclusion in the study. Data on discharge weight,
length, and head circumference was available on 23 970, 17 203,
and 20 885 neonates, respectively. In our data analysis each of
these 3 groups was evaluated as an independent sample.
Data Collection
Using a database from a computer-assisted tool that generates
clinical progress notes on neonates cared for by Pediatrix Medical
Group, Inc., we reviewed data on birth weight, estimated gestational age (this represents the best estimate based on both obstetric
data and neonatal examination), gender, Apgar scores at 5 minutes, race (choices in database are white, black, Hispanic, Native
American and Asian), use of antenatal steroids, use of postnatal
steroids (dexamethasone or hydrocortisone), use of assisted ventilation during the first day of life, use of surfactant, use of respiratory support at 28 days after birth (oxygen, continuous positive
airway pressure, or assisted ventilation), and a diagnosis of necrotizing enterocolitis. We created dichotomous (1/0) variables for
exposure to any type of postnatal steroids (hydrocortisone or
dexamethasone), use of any surfactant, use of respiratory support
at 28 days, and a diagnosis of necrotizing enterocolitis. Neonates
discharged before 28 days were assigned 0 (no support) for the
respiratory variable. We also evaluated data on discharge weight,
length, head circumference, and length of hospital stay. Postmenstrual age was calculated using the estimated gestational age at
birth and the length of hospital stay (ie, estimated gestational age
[length of stay/7]). The database did not include patient identifiers and is maintained as a clinical quality improvement tool.
Statistical Analysis
We used multivariate logistic regression to identify factors
independently associated with the occurrence of extrauterine
growth restriction for each variable. We evaluated all the variables
in Table 2, which on univariate analysis, were found to be associated with the outcome variable (P .05). We incorporated the
variables found to have significant interactions (P .1) with the
outcome variable in the final logistic regression analysis. Variables
were entered into the model using a stepwise selection (P value for
entry and retention .1). Cases with missing values for any of the
independent variables were excluded from the analysis. The total
number of neonates included in each of the final models is listed
in the tables.
RESULTS
The Sample Size and Incidence of Growth Restriction at Discharge in Specific Birth Weight and Estimated Gestational Age
100
313
509
708
856
1104
1317
1743
2396
3521
5166
6638
24 371
93
299
488
672
829
1076
1297
1712
2372
3485
5105
6542
23 970
66
191
304
361
384
438
454
534
632
793
1140
1488
6785
71
64
62
54
46
41
35
31
27
23
22
23
28
82
258
418
565
672
882
1055
1393
1842
2565
3510
3961
17 203
76
206
353
407
448
498
499
535
583
641
772
787
5805
93
80
84
72
67
56
47
38
32
25
22
20
34
94
287
475
655
799
1042
1261
1661
2231
3180
4305
4895
20 885
43
134
195
212
211
223
234
252
311
378
534
648
3375
ARTICLES
Downloaded from pediatrics.aappublications.org at Indonesia:AAP Sponsored on September 18, 2013
46
47
41
32
26
21
19
15
14
12
12
13
16
987
TABLE 2.
Population
Sample
Length 10th
Percentile
Head Circumference
10th Percentile
6785 (28)
5805 (34)
3375 (16)
32 3
1.7 0.5
12 961 (53)
9 (010)
31 3*
1.3 0.4*
4044 (60)*
8 (010)
30 3*
1.3 0.4*
3314 (57)*
8 (010)
30 3*
1.3 0.5*
1839 (55)
8 (010)
4131 (17)
4364 (18)
13 494 (55)
2382 (10)
13 824 (57)
6781 (28)
6707 (28)
2701 (11)
4268 (18)
2171 (9)
612 (3)
1485 (6)
528 (2)
32 27
1264 (18)
1270 (19)
3690 (54)
561 (8)
4200 (62)*
2816 (42)*
2610 (38)*
1593 (24)*
2190 (32)*
905 (13)
328 (5)
957 (14)
273 (4)*
47 31*
1243 (21)
974 (17)
3148 (54)
440 (8)
3838 (66)*
2746 (47)*
2598 (45)*
1613 (28)*
2324 (40)*
999 (17)
360 (6)
965 (17)
247 (4)*
52 31*
676 (20)
655 (19)
1786 (53)
258 (8)
2107 (62)*
1529 (46)*
1388 (41)*
969 (29)*
1265 (38)*
459 (14)
179 (5)
627 (19)
176 (5)*
50 34*
Fig 1. The incidence of extrauterine growth restriction (growth parameter 10th percentile at discharge) in specific birth weight and
gestational age groups. A, Incidence of discharge weight 10th percentile. B, Incidence of discharge length 10th percentile. C, Incidence
of discharge head circumference 10th percentile. Black lines represent the 10th and 90th percentiles base on our previously published
growth curves.3
et al5 reported that at hospital discharge, most infants born between 24 and 29 weeks of gestation had
not achieved the median birth weight of the reference fetus at the same postmenstrual age. The inci-
TABLE 3.
The Sample Size and Incidence of Growth Restriction at Discharge in Specific Discharge Postmenstrual Age Groups
Postmenstrual
Age at
Discharge
(Weeks)
Weight
Assessed
(Grams)
Weight
10th
Percentile at
Discharge
Percent
Length
Assessed
(Centimeters)
Length
10th
Percentile at
Discharge
Percent
Head
Circumference
Assessed
(Centimeters)
Head
Circumference
10th
Percentile at
Discharge
Percent
34
34
35
36
37
38
39
40
41*
Total
586
2875
7570
6150
3225
1534
850
438
742
23 970
2
88
795
1740
1645
1033
622
319
541
6785
0
3
11
28
51
67
73
73
73
28
355
1839
5001
4566
2500
1250
700
370
622
17 203
18
199
792
1410
1162
847
552
297
528
5805
5
11
16
31
46
68
79
80
85
34
475
2335
6144
5450
3059
1462
816
423
721
20 885
14
134
455
623
836
452
292
187
382
3375
3
6
7
11
27
31
36
44
53
16
* Assessed using Centers for Disease Control and Prevention standard gender-specific growth curves.
TABLE 4.
Adjusted Odds Ratios for Factors Associated With Extrauterine Growth Restriction at Discharge (Correcting for Birth
Weight and Estimated Gestational Age at Birth Using Multivariate Logistic Regression)
Variable
23 639
3.9 (3.64.3)
4.2 (3.64.8)
1.8 (1.62.1)
2.7 (2.13.4)
1.6 (1.52.8)
0.84 (0.810.88)
0.45
16 996
2.2 (2.02.4)
2.3 (1.92.6)
1.6 (1.41.9)
1.8 (1.42.3)
1.2 (1.11.3)
0.92 (0.880.96)
0.35
20 627
1.4 (1.31.5)
2.6 (2.33.0)
1.5 (1.31.7)
2.2 (1.72.7)
1.2 (1.11.4)
0.9 (0.860.94)
0.19
0.48
0.92
0.36
0.87
0.21
0.81
ARTICLES
Downloaded from pediatrics.aappublications.org at Indonesia:AAP Sponsored on September 18, 2013
989
We have shown that extrauterine growth restriction remains a common and serious problem for
prematurely born neonates. Although we have made
significant advances in neonatal intensive care, we
need a continued and aggressive effort to study and
define new nutritional strategies that will improve
the nutritional status of prematurely born neonates,
especially the critically ill premature neonate.
APPENDIX
In addition to the authors, the following physicians participated by providing data to the administrative dataset: Harrisburg,
Pennsylvania, K. Lorah; Utica, New York, M. Siriwardena; Boynton Beach, Florida, L. Whetstine; Denver, Colorado, D. Eichorst, J.
Toney; Houston, Texas, R. Rivas, H. Pierantoni, E. ODonnell;
Englewood, Colorado, K. Zarlengo; West Palm Beach, Florida, D.
Kanter; Virginia Beach, Virginia, E. Bollerup; Fredericksburg, Virginia, J. Amin; Spartanburg, South Carolina, V. Iskersky; Watertown, New York, K. Komar; Tarzana, California, J. Banks; Ventura,
California, J. van Houten; Hoboken, New Jersey, S. Mercado;
Stratford, New Jersey, J. Coleman; Trenton, New Jersey, R. Axelrod; Covina, California, G. Martin; Newport Beach, California, L.
Wickham, B. Hannam; Riverside, California, M. Leitner; Las Vegas, Nevada, M. Kaneta; Alexandria, Virginia, L. Goldberg; Albuquerque, New Mexico, R. Nederhoff, S. Swetnam; Aurora, Colorado, M. Brown; Phoenix, Arizona, J. Martin, R. Turbow; Dallas,
Texas, J. Whitfield, T. Brannon; Roanoke, Virginia, R. Allen; Dayton, Ohio, N. Kantor, M. Belcastro; Ogden, Utah, N. Harper, J.
Berger; Columbia, South Carolina, S. Ellis; Panama City, Florida,
D. Sprague; Pensacola, Florida, A. Payne, J. Nagel; Reno, Nevada,
G. Yup; Tacoma, Washington, J. Mulligan, G. Jordan, R. Knudson;
Ponce, Puerto Rico, E. Ochoa, J. Rodriguez; Santurce, Puerto Rico,
F. Caceras; Barrington, Illinois, F. Uraizee; Fort Worth, Texas, M.
Stevener, R. Sidebottom, D. Turbeville, M. Stanley; Charleston,
990
REFERENCES
1. Embleton NE, Pang N, Cooke RJ. Postnatal malnutrition and growth
retardation: an inevitable consequence of current recommendations in
preterm infants? Pediatrics. 2001;107:270 273
2. Lucas A, Morley R, Cole TJ. Randomised trial of early diet in preterm
babies and later intelligence quotient. BMJ. 1998;317:14811487
3. Thomas P, Peabody J, Turnier V, Clark RH. A new look at intrauterine
growth and the impact of race, altitude, and gender. Pediatrics. 2000;
106(2). Available at: http://www.pediatrics.org/cgi/content/full/106/
2/e21
4. National Center of Health Statistics. National Center of Health Statistics.
Clinical Growth Charts. Available at: http://www.cdc.gov/
growthcharts/
5. Ehrenkranz RA, Younes N, Lemons JA, et al. Longitudinal growth of
hospitalized very low birth weight infants. Pediatrics. 1999;104:280 289
6. Dusick A, Vohr BR, Wright LL, et al. Failure-to-thrive in ELBW infants
at 18 months is increased by using the new NCHS growth standards
[abstract 1945]. Pediatr Res. 2001;49:340A
7. Hack M, Breslau N, Weissman B, Aram D, Klein N, Borawski E. Effect
of very low birth weight and subnormal head size on cognitive abilities
at school age. N Engl J Med. 1991;325:231237
8. Stark AR, Carlo WA, Tyson JE, et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child
Health and Human Development Neonatal Research Network. N Engl
J Med. 2001;344:95101
9. Finer NN, Craft A, Vaucher YE, Clark RH, Sola A. Postnatal steroids:
short-term gain, long-term pain? [see comments]. J Pediatr. 2000;137:
9 13
10. Goldenberg RL, Wright LL. Repeated courses of antenatal corticosteroids. Obstet Gynecol. 2001;97:316 317
11. Lenke R. Safety of multiple courses of corticosteroid treatment. Am J
Obstet Gynecol. 2000;182:478 479
12. Whitelaw A, Thoresen M. Antenatal steroids and the developing brain.
Arch Dis Child Fetal Neonatal Ed. 2000;83:F154 F157
References
Citations
Subspecialty Collections
Reprints